These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 33421192)

  • 21. Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay.
    Abenavoli L; Giubilei L; Procopio AC; Spagnuolo R; Luzza F; Boccuto L; Scarpellini E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal Fungal Microbiota (Mycobiome) Study as a Potential Tool for Precision Medicine in Inflammatory Bowel Disease.
    Balderramo DC; Romagnoli PA; Granlund AVB; Catalan-Serra I
    Gut Liver; 2023 Jul; 17(4):505-515. PubMed ID: 37305948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients.
    Dheer R; Davies JM; Quintero MA; Damas OM; Deshpande AR; Kerman DH; Sawyer WP; Pignac-Kobinger J; Ban Y; Fernandez I; Burgueno JF; Phillips MC; Abreu MT
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):387-402. PubMed ID: 31740421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease.
    Maronek M; Link R; Ambro L; Gardlik R
    Cells; 2020 Apr; 9(4):. PubMed ID: 32325706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diet-Microbiota Interactions in Inflammatory Bowel Disease.
    Sugihara K; Kamada N
    Nutrients; 2021 May; 13(5):. PubMed ID: 34062869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of diet on the gut mycobiome and potential implications in inflammatory bowel disease.
    Buttar J; Kon E; Lee A; Kaur G; Lunken G
    Gut Microbes; 2024; 16(1):2399360. PubMed ID: 39287010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
    Aldars-García L; Marin AC; Chaparro M; Gisbert JP
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
    Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: fungal alterations in inflammatory bowel diseases.
    Lam S; Zuo T; Ho M; Chan FKL; Chan PKS; Ng SC
    Aliment Pharmacol Ther; 2019 Dec; 50(11-12):1159-1171. PubMed ID: 31648369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. More on the interplay between gut microbiota, autophagy, and inflammatory bowel disease is needed.
    Subramanian A; Jahabardeen A; Thamaraikani T; Vellapandian C
    World J Gastroenterol; 2024 Jul; 30(27):3356-3360. PubMed ID: 39086745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.
    Imai T; Inoue R; Kawada Y; Morita Y; Inatomi O; Nishida A; Bamba S; Kawahara M; Andoh A
    J Gastroenterol; 2019 Feb; 54(2):149-159. PubMed ID: 30478724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The important role of fungi in inflammatory bowel diseases.
    Wang S; Zhang YR; Yu YB
    Scand J Gastroenterol; 2021 Nov; 56(11):1312-1322. PubMed ID: 34392745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inter-kingdom relationships in Crohn's disease explored using a multi-omics approach.
    Frau A; Ijaz UZ; Slater R; Jonkers D; Penders J; Campbell BJ; Kenny JG; Hall N; Lenzi L; Burkitt MD; Pierik M; Darby AC; Probert CSJ
    Gut Microbes; 2021; 13(1):1930871. PubMed ID: 34241567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiota, inflammatory bowel disease and colorectal cancer.
    Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.
    Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A
    Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiota and mucosal defense in IBD: an update.
    Stange EF; Schroeder BO
    Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):963-976. PubMed ID: 31603356
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
    Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
    J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease.
    Ekstedt N; Jamioł-Milc D; Pieczyńska J
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage interactions with fungi and bacteria in inflammatory bowel disease.
    Leonardi I; Li X; Iliev ID
    Curr Opin Gastroenterol; 2018 Nov; 34(6):392-397. PubMed ID: 30239343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.